Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods
NCT07211061 · View on ClinicalTrials.gov ↗
Study Summary
Subjects who have shown evidence of gingivitis and plaque will be enrolled in this study. Each subject will be randomly assigned to one of two treatment products. The regimen group will be asked to brush 2x a day in using a power brush (2 minutes of brushing), followed by using 20 ml of mouth rinse for 30 seconds for 6 weeks. The negative control group will be asked to brush 2x a day using a manual toothbrush in their customary manner for 6 weeks. Oral Soft Tissue (OST) assessments, gingivitis and plaque measurements will be taken at 4 time-points: Baseline (BL); Week 1; Week 3; and Week 6.
Conditions Studied
Interventions
- DRUG Stannous Fluoride Dentifrice
- DRUG Sodium Fluoride Dentifrice
- DEVICE electric toothbrush
- DRUG Cetylpyridinium Chloride (CPC)
- DEVICE manual toothbrush
Study Locations (1)
Nevada
- Bio-Sci Research (Out of Business) — Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2011-09-21 |
| Est. Completion | 2011-11-10 |
| Phase | Phase 4 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07211061
The ClinicalTrials.gov registry entry for NCT07211061 describes a study currently listed as completed. It is categorized as Phase 4, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 25 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Gingivitis appearing as the primary indexed condition, and to 5 interventions — of which Stannous Fluoride Dentifrice is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT07211061 reports 1 study location spanning 1 distinct geographic area — top geographies include Nevada. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT07211061 about?
NCT07211061 is a clinical study titled "A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods". Subjects who have shown evidence of gingivitis and plaque will be enrolled in this study. Each subject will be randomly assigned to one of two treatment products. The regimen group will be asked to brush 2x a day in using a power brush (2 minutes of brushing), followed by using 20 ml of mouth rinse ...
What is the current status of trial NCT07211061?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 69 participants. The study started on 2011-09-21. Estimated completion is 2011-11-10.
What conditions does trial NCT07211061 study?
This clinical trial studies the following conditions: Gingivitis. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT07211061?
The interventions under investigation include: Stannous Fluoride Dentifrice (DRUG), Sodium Fluoride Dentifrice (DRUG), electric toothbrush (DEVICE), Cetylpyridinium Chloride (CPC) (DRUG), manual toothbrush (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT07211061?
This trial is sponsored by Procter and Gamble, which has 25 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT07211061 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.